A finder tool given equal billing with the clinical content.
Vaccine site design puts availability information alongside the clinical and public-health content, not buried below it, because a visitor who wants to know where to get vaccinated is a large share of the real audience.
Burying availability information below several sections of clinical and public-health content loses the visitor who came specifically to find where to get vaccinated — the finder function sits alongside the content, not in a footer link.
A visitor checking vaccine availability wants a location and a date, not a paragraph, and static text that goes stale within weeks fails that visitor specifically. That behaviour is what the information architecture has to be designed around, not a generic hero-and-three-columns layout.
An architecture giving a finder tool equal billing with clinical content, a component system serving HCP and public audiences from the same structure, and a review of where availability information is currently under-prioritised.
Burying availability information below several sections of clinical and public-health content loses the visitor who came specifically to find where to get vaccinated — the finder function gets equal billing with the content, not a footer link.
A vaccine site is visited by healthcare professionals checking schedules and contraindications, by public health and procurement bodies assessing supply, and by members of the public who have arrived with a concern. Their needs conflict directly: the professional wants prescribing detail, the public reader needs plain language and reassurance, and the procurement reader wants presentations, cold chain requirements and supply position. Building these as genuinely separate routes with distinct entry points, rather than as one site with a professional area bolted on, is what keeps each usable and keeps the regulatory position clean.
Vaccine pages attract sharp, sometimes coordinated attention, and traffic can rise very quickly around a campaign, a health authority announcement or a news story. That places demands most pharmaceutical sites never face: capacity to absorb sudden load, resilience against automated abuse of any form or comment feature, careful control of what can be embedded or quoted out of context, and the ability to publish a correction quickly through a process that still satisfies review. These are architectural decisions rather than content decisions, and they are difficult and expensive to retrofit once the site is live.
What comes up when scoping a site for this category.
Mostly the public and healthcare professionals, on the same domain, searching something close to “vaccine availability near me” rather than browsing casually. The public visitor usually wants a location and a date, while the HCP visitor is checking dosing schedules or clinical guidance, and both arrive expecting information that reflects the current situation rather than a static page written months earlier.
The two audiences need clearly distinct sections from the entry point, since a public visitor checking availability and an HCP checking dosing guidance are looking for different depth of detail entirely. A simple identification step at the top of the page can route each visitor to the right content immediately, rather than mixing consumer-level and clinical-level information together and asking each reader to filter it themselves.
Yes — that includes availability finders, HCP-specific dosing and guidance portals, and content workflows built to stay current as recommendations change. See Vaccines for the full range of platforms and content we build for this sector, most of it built around keeping time-sensitive information from going stale.
Yes — the same finder can surface different detail depending on whether the visitor identifies as a healthcare professional or a member of the public. A public visitor typically needs a location, date, and eligibility summary, while an HCP visitor needs dosing intervals and clinical guidance, and the same underlying data can serve both without duplicating the finder itself.
Staying strictly professional is a defensible choice, but it should be made deliberately rather than by default, because the public search demand does not disappear — it is simply met by someone else. Where a company does choose to address it, the workable structure keeps public content entirely separate from prescribing material, sources every statement to approved documentation or a health authority, and routes it through medical affairs rather than marketing review. That is a narrower and more sustainable commitment than a general communications campaign.
A site that looks fine and still does not serve the public and healthcare professionals, on the same domain well, usually because of availability information that is static text instead of a functional, current tool underneath it. Tell us your situation and we will tell you what we would fix first. Tell us your situation and we will tell you what a rebuild for the public and healthcare professionals, on the same domain would actually change.